Peptide questions · Enicepatide

How long does enicepatide take to work?

Reviewed Evidence: ModeratePublished by PepVault

Enicepatide’s onset is days–2 weeks, its peak effect comes at 48 weeks (phase 2 endpoint, no plateau), and its typical duration is ongoing, by the library’s timeline (backed by moderate evidence).

The timeline’s basis: Phase 1 (Chakravarthy 2026, Mol Metab; NCT04838405), obesity phase 2 (Roche, Jan-27-2026; ADA 2026 poster; NCT06525935), diabetes phase 2 (Roche, Sep-22-2026; NCT06628362), ENITH records on ClinicalTrials.gov. Investigational.

Enicepatide week by week

The library places five of its research notes on enicepatide on the days they cover, from day 1 to day 336 and on: 4 on randomized trials and 1 on clinical data.

Day 1 is the first day of a run. Each bar is one of the library’s research notes, placed on the days it covers.

The enicepatide notes by day
WhenThe noteEvidence
Days 1–28 (weeks 1–4)Two milligrams, the first stepRandomized trial
Days 29–112 (weeks 5–16)Through the middle stepsRandomized trial
Days 85–336 (weeks 13–48)With type 2 diabetesRandomized trial
Days 113–336 (weeks 17–48)The top dose testedRandomized trial
From day 337 onA long-term medicine, not a courseClinical data
A smiling man in a grey t-shirt in his living room, holding his phone

Model. Individual results vary.

PepVault for iPhone

Track enicepatide in PepVault

Log each dose and your weekly check-ins, and see your own weeks add up.

Download on the App Store

7 days free on the yearly plan for new subscribers.

The enicepatide timeline’s milestones

The library’s timeline for enicepatide marks 4 points from week 1 to week 48, backed by moderate evidence overall.

  • Week 1: Commonly reported: appetite dropping in the first days, with nausea most likely early in each step
  • Week 4: Phase 1: about 5% to 8% average loss after 4 weekly doses vs 0.5% on placebo
  • Week 27: The obesity phase 2 trial reached each group's top dose by about week 27
  • Week 48: Obesity phase 2 endpoint: about 22.5% more loss than placebo at 24 mg, not yet levelling off

The weeks are the library’s reference timeline from studies and reported use, not a promise of what any one person will notice.

Why enicepatide takes that long

Enicepatide’s half-life is about 5.5 days (132 hours), so one dose is about 96.9% cleared after 28 days.

On its schedule (Weekly) the doses overlap, and the level of enicepatide keeps climbing for about 22–28 days before it levels off, so the first 22–28 days run below the level the later weeks hold.

The notes on enicepatide follow the trials’ dose steps, 2mg, 8mg and 24mg, so the later weeks also describe higher steps than the first ones; these are steps from studies, not a schedule for a person.

Enicepatide against other metabolic & GLP-1 compounds

The library holds an onset-and-peak timeline for 21 metabolic & GLP-1 compounds, enicepatide among them; 15 of the others share its onset of days–2 weeks.

When metabolic & GLP-1 compounds start to act and peak, by the library’s timelines
CompoundOnsetPeak effect
SemaglutideDays–2 weeks60–68 weeks
TirzepatideDays–2 weeks72+ weeks
RetatrutideDays–2 weeks48+ weeks
DulaglutideDays–2 weeks24–52 weeks (glucose)
ExenatideFirst dose (after-meal glucose)24–30 weeks (HbA1c)
Setmelanotide1–2 weeks (hunger)52 weeks (BMI)
OrforglipronDays–2 weeks72 weeks (trial endpoint)
SurvodutideDays–2 weeks76 weeks (trial endpoint)
MazdutideDays–2 weeks48–60 weeks
PemvidutideDays–2 weeks48+ weeks
CagrilintideDays–2 weeks26–68 weeks (trial endpoints)
PramlintideFirst meal (fullness, after-meal glucose)16–52 weeks (weight, HbA1c)
CagriSemaDays–2 weeks68+ weeks
EloralintideDays–2 weeks48 weeks (phase 2 endpoint)
PetrelintideDays–2 weeks42 weeks (phase 2, still falling)
AmycretinDays–2 weeks36 weeks (longest trial so far)
VK2735Days–2 weeks78 weeks (phase 3 endpoint, not yet read out)
EnicepatideDays–2 weeks48 weeks (phase 2 endpoint, no plateau)
EcnoglutideDays–2 weeks48 weeks (phase 3, no plateau)
EfinopegdutideWeeks24–52 weeks (trial endpoints)
SLU-PP-332Unknown in peopleUnknown in people

Questions people ask

How long does enicepatide take to work?

Enicepatide’s onset is days–2 weeks, its peak effect comes at 48 weeks (phase 2 endpoint, no plateau), and its typical duration is ongoing, by the library’s timeline (backed by moderate evidence).

When does enicepatide reach its peak effect?

By the library’s timeline, enicepatide’s peak effect comes at 48 weeks (phase 2 endpoint, no plateau), backed by moderate evidence.

How long is enicepatide usually run?

The library’s timeline gives enicepatide’s typical duration as ongoing; its cycle note says: Used continuously, once weekly, in its trials: 48 weeks in both phase 2 trials, with the dose stepped up over as long as 27 weeks.

What does the library say about the first days on enicepatide?

Its first note on enicepatide, for days 1–28 (weeks 1–4), is “Two milligrams, the first step”, resting on randomized trials.

More on enicepatide

Track it in the app

PepVault for iPhone

Track enicepatide in PepVault

Log each dose and your weekly check-ins, and see your own weeks add up.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo